Rutgers New Jersey Medical School-department of Hematology oncology ( Site 2053) is a clinical research site located in Newark, New Jersey, United States 07103.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Rutgers New Jersey Medical School-department of Hematology oncology ( Site 2053) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Head and Neck Neoplasms.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rutgers New Jersey Medical School-department of Hematology oncology ( Site 2053) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rutgers New Jersey Medical School-department of Hematology oncology ( Site 2053) has 1 clinical trials on record, with 1 currently active. Their work covers Head and Neck Neoplasms.
Rutgers New Jersey Medical School-department of Hematology oncology ( Site 2053) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.